When a fellow pilot investigated the crash, he determined that a series of critical errors may have added up to catastrophe for the famous aviator on her final flight.
This clinical-stage biotech develops antibody therapeutics targeting cancer, with a pipeline focused on oncology and immunotherapy markets.